Profile and factors determining outcome in a cohort of cystic fibrosis patients seen at the Aga Khan University Hospital, Karachi, Pakistan.
暂无分享,去创建一个
[1] G. Alexander,et al. Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[2] R. Lodha,et al. Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis. , 2003, Indian pediatrics.
[3] S. Emerson,et al. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study , 2003, The Lancet.
[4] A. Morabito,et al. Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome , 2002, Hepatology.
[5] R. Prasad,et al. Cystic fibrosis in north Indian children , 2002, Indian journal of pediatrics.
[6] R. Sokol,et al. Cholangiocyte Biology and Cystic Fibrosis Liver Disease , 2001, Seminars in liver disease.
[7] Z. Bhutta,et al. Genetic analysis of cystic fibrosis in Pakistan: a preliminary report. , 2000, JPMA. The Journal of the Pakistan Medical Association.
[8] B. Strandvik,et al. Natural history of liver disease in cystic fibrosis , 1999, Hepatology.
[9] F. Al-Mahroos,et al. Cystic fibrosis in bahrain incidence, phenotype, and outcome. , 1998, Journal of tropical pediatrics.
[10] S. Kabra,et al. Delta F 508 molecular mutation in Indian children with cystic fibrosis. , 1996, The Indian journal of medical research.
[11] P. Farrell,et al. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. , 1996, Pediatrics.
[12] S. Kabra,et al. Cystic fibrosis-an Indian perspective on recent advances in diagnosis and management , 1996, Indian journal of pediatrics.
[13] S. Higgins,et al. Cystic fibrosis in children from ethnic minorities in the West Midlands. , 1994, Respiratory medicine.
[14] S. Bhattacharya,et al. Absence of cystic fibrosis mutations in a large Asian population sample and occurrence of a homozygous S549N mutation in an inbred Pakistani family. , 1993, Journal of medical genetics.
[15] J. Littlewood,et al. Cystic fibrosis in Asians. , 1993, Archives of disease in childhood.
[16] M. Tanner,et al. Prevalence of liver disease in cystic fibrosis. , 1991, Archives of disease in childhood.
[17] M. Welsh,et al. Generation of cAMP-activated chloride currents by expression of CFTR. , 1991, Science.
[18] A. Markham,et al. ΔF508 testing of the DNA bank of the Royal Manchester Children's Hospital , 1990, Human Genetics.
[19] R. Wilmott,et al. Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosa. , 1985, American journal of diseases of children.
[20] R. Grand,et al. Gastrointestinal manifestations of cystic fibrosis: a review. , 1981, Gastroenterology.
[21] D. Rushton,et al. Cystic fibrosis in 3 Pakistani children. , 1974, Archives of disease in childhood.
[22] E. Girodon,et al. Identification of cystic fibrosis mutations in the United Arab Emirates , 1998 .
[23] M. Schwarz,et al. Detection of five novel mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in Pakistani patients with cystic fibrosis: Y569D, Q98X, 296+12(T>C), 1161delC and 621+2(T>C) , 1998, Human mutation.
[24] P. Pignatti,et al. Genotype-phenotype correlations in Cystic Fibrosis. , 1997 .
[25] S. Fitzsimmons,et al. The changing epidemiology of cystic fibrosis. , 1993, The Journal of pediatrics.
[26] C. Boeck. Correlation between genotype and phenotype in patients with cystic fibrosis , 1993 .